Literature DB >> 29530743

Epidemiology, risk factors and outcomes of multi-drug-resistant bloodstream infections in haematopoietic stem cell transplant recipients: importance of previous gut colonization.

A M Ferreira1, F Moreira2, T Guimaraes3, F Spadão3, J F Ramos4, M V Batista4, J S Filho2, S F Costa5, V Rocha6.   

Abstract

BACKGROUND: Bloodstream infections (BSI) are a major complication in the early phase of a haematopoietic stem cell transplant (HSCT). AIM: To describe the incidence and risk factors for BSI occurring in the pre-engraftment phase of HSCT, and its impact on mortality.
METHODS: Clinical variables of 232 HSCT patients were analysed retrospectively between 2014 and 2015. Univariate Cox regression analyses were performed to test the association between each covariate and the outcome. Covariates with P < 0.10 on univariate analysis were included in a multiple Cox regression analysis using a backward elimination method.
FINDINGS: The cumulative incidence of BSI was 25.4%, mainly caused by Gram-negative bacteria (GNB) (55.2%). Approximately 40.5% of the patients had gut colonization by multi-drug-resistant (MDR) bacteria (vancomycin-resistant enterococcus and carbapenem-resistant GNB). Among patients colonized by MDR GNB, 20% developed an overt BSI due to MDR bacteria with the same pattern of sensitivity. Of the 13 deaths related to infection, 10 were patients with BSI caused by MDR GNB. The independent risk factors for BSI were gut colonization by MDR bacteria including GNB (P < 0.001) and duration of neutropenia >10 days (P = 0.005), and those associated with BSI caused by MDR bacteria were age >62 years (P = 0.03), use of total parenteral nutrition (TPN) (P < 0.001) and previous gut colonization by MDR GNB (P = 0.002).
CONCLUSIONS: Previous gut colonization by MDR was an independent risk factor for BSI, together with TPN and age, and had an impact on outcome. These findings suggest that gut decolonization may be a potential strategy to prevent BSI.
Copyright © 2018 The Healthcare Infection Society. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Colonization; Haematopoietic stem cell transplant; Multi-drug-resistant bacteria

Mesh:

Year:  2018        PMID: 29530743     DOI: 10.1016/j.jhin.2018.03.004

Source DB:  PubMed          Journal:  J Hosp Infect        ISSN: 0195-6701            Impact factor:   3.926


  6 in total

1.  Bloodstream Infections and Delayed Antibiotic Coverage Are Associated With Negative Hospital Outcomes in Hematopoietic Stem Cell Transplant Recipients.

Authors:  Joyce Ji; Jeff Klaus; Jason P Burnham; Andrew Michelson; Colleen A McEvoy; Marin H Kollef; Patrick G Lyons
Journal:  Chest       Date:  2020-06-17       Impact factor: 9.410

2.  Gut resistome plasticity in pediatric patients undergoing hematopoietic stem cell transplantation.

Authors:  Federica D'Amico; Matteo Soverini; Daniele Zama; Clarissa Consolandi; Marco Severgnini; Arcangelo Prete; Andrea Pession; Monica Barone; Silvia Turroni; Elena Biagi; Patrizia Brigidi; Riccardo Masetti; Simone Rampelli; Marco Candela
Journal:  Sci Rep       Date:  2019-04-04       Impact factor: 4.379

3.  Infection control management and surveillance of carbapenem-resistant Gram-negative bacteria in hematopoietic stem cell recipients.

Authors:  Claas Baier; Maleen Beck; Viktoria Panagiota; Catherina Lueck; Daniel Kharazipour; Sophie Charlotte Hintze; Robin Bollin; Ella Ebadi; Stefan Ziesing; Matthias Eder; Franz-Christoph Bange; Gernot Beutel
Journal:  Antimicrob Resist Infect Control       Date:  2019-10-21       Impact factor: 4.887

4.  Revisiting Infectious Complications Following Total Parenteral Nutrition Use During Hematopoietic Stem Cell Transplantation.

Authors:  Halina Rubin; Jayesh Mehta; Jessica L Fong; Deborah Greenberg; Solomiya GrusChak; Steven Trifilio
Journal:  J Adv Pract Oncol       Date:  2020-09-01

5.  Effectiveness of surveillance cultures for high priority multidrug-resistant bacteria in hematopoietic stem cell transplant units.

Authors:  Elisa Teixeira Mendes; Matias Chiarastelli Salomão; Lísia Moura Tomichi; Maura Salaroli Oliveira; Mariana Graça; Flavia Rossi; Fernanda Sapadao; Thais Guimarães; Vanderson Rocha; Silvia Figueiredo Costa
Journal:  Rev Inst Med Trop Sao Paulo       Date:  2021-11-08       Impact factor: 1.846

6.  Multidrug resistant bacteremia in hematopoietic stem cell transplant recipients.

Authors:  Ameni Mellouli; Yosra Chebbi; Rym El Fatmi; Anis Raddaoui; Amel Lakhal; Lamia Torjmane; Nour Ben Abdeljelil; Dorra Belloumi; Salwa Ladeb; Tarek Ben Othmen; Wafa Achour
Journal:  Tunis Med       Date:  2021-02
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.